Publications
Mangu C, Cossa M, Ndege R, Khosa C, Leukes V, de la Torre-Pérez L, Machiana A, Kivuma B, Mnzava D, Zachariah C, Manjate P, Tagliani E, Schacht C, Buech J, Singh S, Ehrlich J, Riess F, Sanz S, Kranzer K, Cox H, Sabi I, Nguenha D, Meggi B, Weisser M, Ntinginya N, Schumacher S, Ruhwald M, Penn-Nicholson A, Garcia-Basteiro A.L, TB-CAPT Consortium. Expanding Xpert MTB/RIF Ultra® and LF-LAM testing for diagnosis of tuberculosis among HIV-positive adults admitted to hospitals in Tanzania and Mozambique: a randomized controlled trial (the EXULTANT trial). BMC Infect Dis. 2024;24:831. DOI: 10.1186/s12879-024-09651-z
Ndege R, Rohacek M, Bani F, Ngome O, Okuma J, Sasamalo M, Mnzava D, Reither K, Vanobberghen F, Hella J, Paris D.H, Weisser M. Diagnostic yield of urine Xpert MTB/RIF ultra in adults with suspected extrapulmonary tuberculosis. Open Forum Infect Dis. 2024;11(7):ofae338. DOI: 10.1093/ofid/ofae338
Ndege R. Sero-negative HIV, a need for presumptive HIV diagnosis in adults in developing countries. HIV Med. 2024;25(2):306-307. DOI: 10.1111/hiv.13564
Anton-Vazquez V, Mnzava D, Okuma J, Mlembe S, Lo Riso L, Sanchez J.M, Ndege R, Vedastus Kalinjuma A, Kimera N, Eichenberger A, Nicoletti G.J, Wilson H, Vanobberghen F, Weisser M, KIULARCO Study Group. Improving anaemia diagnosis using peripheral blood smear with remote interpretation in adults living with HIV with moderate to severe anaemia: a prospective study nested within the Kilombero and Ulanga antiretroviral cohort. PLoS One. 2023;18(10):e0293084. DOI: 10.1371/journal.pone.0293084
Chuwa F, Kivuma B, Ndege R, KIULARCO Study Group. Repeated false-negative HIV rapid test results in a patient presenting to care with advanced HIV disease: a case report. IDCases. 2023;31:e01719. DOI: 10.1016/j.idcr.2023.e01719
Ndege R, Ngome O, Vanobberghen F, Bani F, Temba Y, Wilson H, Hella J, Gingo W, Sasamalo M, Mnzava D, Kimera N, Hiza H, Wigayi J, Mapesi H, Kato I.B, Mhimbira F, Reither K, Battegay M, Paris D.H, Weisser M, Rohacek M. Ultrasononography in managing extrapulmonary tuberculosis: a randomized, controlled, parallel, superiority, open-label trial. Clin Infect Dis. 2023;76(6):1013-1021. DOI: 10.1093/cid/ciac871
Ntamatungiro A.J, Eichenberger A, Okuma J, Vanobberghen F, Ndege R, Kimera N, Francis J.M, Kagura J, Weisser M, Kilombero and Ulanga Antiretroviral Cohort (KIULARCO) Study Group. Transitioning to dolutegravir in a programmatic setting: virological outcomes and associated factors among treatment-naive patients with HIV-1 in the Kilombero and Ulanga Antiretroviral Cohort in rural Tanzania. Open Forum Infect Dis. 2023;10(7):ofad321. DOI: 10.1093/ofid/ofad321